161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis

Background Clinical trials in adult and pediatric populations in Europe have demonstrated the efficacy and safety of 300IR 5-grass pollen sublingual allergen immunotherapy (SLIT) tablets for the treatment of grass pollen-induced rhinoconjunctivitis. Here we present an assessment of this treatment in the US.